Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: GLP-1 and Hypoglycemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating GLP-1 and hypoglycemia in type 2 diabetes, sponsored by University of Maryland, Baltimore, is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonist

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Type 2 Diabetes Mellitus | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING